Block Grant K01IP000165

This $3,443,599 Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) will support the development, implementation, and evaluation of a Motivational Interviewing (MI) training program for primary care providers (PCPs) to address COVID-19 and influenza vaccine hesitancy among adult patients. The University of Massachusetts Medical School (UMass Medical) will lead this 22-month project focused on...

This National Science Foundation (NSF) Project Grant award under the Social, Behavioral, and Economic Sciences (CFDA 47.075) program provides $442,478 to the University of California, Los Angeles (UCLA) to conduct research on the sociodemographic influences on vaccine decision-making. The multi-modal study examines how local illness models, individual-level factors, sociodemographic characteristics, and social learning shape vaccination perceptions and practices, particularly in underserved...

This $1,225,986 Cooperative Agreement awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support a study to investigate the factors that shape the strength, durability, and breadth of the adaptive immune response to influenza vaccination. The researchers at the University of Chicago will conduct a randomized, placebo-controlled trial to identify individuals with strong versus weaker B and T...

The National Science Foundation (NSF) awarded a $448,823 Project Grant under its Social, Behavioral, and Economic Sciences program (CFDA 47.075) to the Trustees of Boston University. This two-year grant, running from September 1, 2023 to August 31, 2025, aims to assess the effectiveness of various health communication tactics employed by federal, state, and local agencies to encourage vaccine uptake. The project will build a database of vaccine messaging from public health agencies, evaluate the...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $534,242.00 to the New York Blood Center, Inc. to study the immune and behavioral responses of transgender women to seasonal COVID-19 vaccines. The goal is to understand how gender-affirming hormone therapy impacts immune function and vaccine efficacy, as well as to develop an intervention to improve COVID-19 vaccine...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $586,250 Project Grant (CFDA 93.855) to the University of Massachusetts Medical School to investigate how distinct age-associated B cell subsets can protect the aged from influenza. The project aims to determine the potential of different B cell subsets to respond to influenza infection and generate antibody-secreting cells, B cell memory, and long-lived antibody-secreting cells. Researchers will also compare the ability...

This $375,000 Project Grant awarded by the National Science Foundation (NSF) under its Social, Behavioral, and Economic Sciences (CFDA 47.075) program supports a community-engaged study examining the role of social media influencers in addressing vaccine information integrity and vaccine hesitancy. The project will use social listening tools to analyze emerging narratives about a new respiratory syncytial virus (RSV) vaccine on social media, and then collaborate with 8 lifestyle influencers to...

This federal Project Grant award of $149,528 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to investigate the mechanisms underlying sex differences in vaccine-induced immunity. The principal investigator at The Johns Hopkins University will test the hypothesis that differential activation of the mTOR signaling pathway and metabolic shifts in B cells are central to the observed...

This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to develop and test a novel stakeholder-informed intervention to improve routine vaccination of hospitalized children. The $220,000 award will fund the "Presumptively Initiating Vaccines and Optimizing Talk for Inpatients (PIVOT-IN)" intervention, which includes: 1) a standardized screening...

This National Science Foundation Project Grant award of $525,000 supports research on concealing infectious disease at the University of Michigan from April 2022 through March 2025. The project aims to better understand decisions to conceal infectious illness and the psychological consequences of doing so. Specifically, the award will fund a series of descriptive studies and experiments to examine factors associated with concealing sickness from friends, coworkers, and strangers depending on...